Internal Medicine, Rheumatology · Albuquerque, NM
NPI
1801175559
Since 2011
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4100 High Resort Blvd SE
Albuquerque, NM, 87124
Phone (505) 291-2222
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
327 services
Medicare patients, 2024
167
Average age 69
Drug cost, 2024
$3.5M
2,552 prescriptions
Company payments, 2025
$205
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chandrahasa Annem was code 99214 (office e&m - established), 233 times for 141 patients. In total Chandrahasa Annem billed 327 services in 11 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 233 | 141 | $64.21 | $15K |
| 99215 Office E&M - Established | Office | 69 | 57 | $104.23 | $7,192 |
By year: 2022 $35K for 402 services; 2023 $29K for 410 services; 2024 $24K for 327 services.
Medicare prescription drug claims, 2024
In 2024, the drug Chandrahasa Annem prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 412 prescriptions and refills. In total Chandrahasa Annem wrote 2,552 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 412 | 1,147 | 160 | $15K |
| Methotrexate Methotrexate Sodium | 349 | 883 | 113 | $11K |
| Prednisone Generic | 247 | 395 | 95 | $2,593 |
| Leflunomide Generic | 155 | 392 | 50 | $7,514 |
| Gabapentin Generic | 121 | 159 | 24 | $1,463 |
| Alendronate Sodium Generic | 99 | 247 | 30 | $1,087 |
| Humira(Cf) Pen Adalimumab | 81 | 99 | 15 | $687K |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 78 | 78 | Under 11 | $199K |
| Xeljanz Xr Tofacitinib Citrate | 75 | 75 | Under 11 | $426K |
| Methylprednisolone Generic | 72 | 76 | 41 | $729 |
| Rinvoq Upadacitinib | 71 | 73 | Under 11 | $472K |
| Enbrel Sureclick Etanercept | 52 | 52 | Under 11 | $383K |
| Diclofenac Sodium Generic | 43 | 51 | 20 | $1,117 |
| Allopurinol Generic | 39 | 110 | 16 | $657 |
| Celecoxib Generic | 36 | 58 | 11 | $632 |
Brand drugs: - claims; generic drugs: 1,935 claims; opioid claims: 30.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chandrahasa Annem $205 ($205 in general payments such as food, travel and fees) from 4 companies. The largest payer was Amgen Inc. with $84.05.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.